The House Committee on Oversight and Government Reform Thursday jumped in the middle of the Federal Trade Commission’s ongoing data security trial against medical testing facility LabMD, holding a three-hour hearing that questioned whether the agency’s case is appropriate or fair.
The FTC is “using its regulatory authority not to help protect consumers but to get simple consent decrees using the unlimited power it has,” said committee chairman Darrell Issa, R-Calif.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
